Bodenrader Mark
- SEC CIK
- 0001830371
No open-market purchases or sales filed in the past year.
Current role at each company
- CERE Cerevel Therapeutics Holdings, Inc.See Remarksas of Aug 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bodenrader Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 (view filing) | Dec 20 | 1 day | Bodenrader MarkSee Remarks | SSale | −7.89K | $41.42 | −$326.8K | −30.8%17.7K after | |
| Jun 5, 2023 (view filing) | Jun 2 | 3 days | Bodenrader MarkSee Remarks | SSale | −1.90K | $32.95 | −$62.4K | −25.5%5.52K after | 10b5-1 |